150 related articles for article (PubMed ID: 3581706)
1. CRP in the management of polymyalgia rheumatica and giant cell arteritis.
Schreiber S
Clin Rheumatol; 1987 Mar; 6(1):97-8. PubMed ID: 3581706
[No Abstract] [Full Text] [Related]
2. Relationship of the erythrocyte sedimentation rate to acute phase proteins in polymyalgia rheumatica and giant cell arteritis.
Park JR; Jones JG; Hazleman BL
Ann Rheum Dis; 1981 Oct; 40(5):493-5. PubMed ID: 6171213
[TBL] [Abstract][Full Text] [Related]
3. Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up.
Kyle V; Cawston TE; Hazleman BL
Ann Rheum Dis; 1989 Aug; 48(8):667-71. PubMed ID: 2782977
[TBL] [Abstract][Full Text] [Related]
4. Microheterogeneity of alpha 1-antichymotrypsin in the management of giant-cell arteritis and polymyalgia rheumatica.
Hachulla E; Laine A; Hayem A
Clin Sci (Lond); 1990 Jun; 78(6):557-64. PubMed ID: 2165887
[TBL] [Abstract][Full Text] [Related]
5. Serum immunoglobulin G4 in giant cell arteritis and polymyalgia rheumatica.
Burkel M; Arndt F; Schirmer JH; Moosig F; Holle JU
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):94-97. PubMed ID: 27974093
[TBL] [Abstract][Full Text] [Related]
6. Serum C-reactive protein in polymyalgia rheumatica. A prospective serial study.
Mallya RK; Hind CR; Berry H; Pepys MB
Arthritis Rheum; 1985 Apr; 28(4):383-7. PubMed ID: 2859021
[TBL] [Abstract][Full Text] [Related]
7. Alpha 1-antichymotrypsin, C-reactive protein and erythrocyte sedimentation rate in polymyalgia rheumatica and giant cell arteritis.
Pountain GD; Calvin J; Hazleman BL
Br J Rheumatol; 1994 Jun; 33(6):550-4. PubMed ID: 8205403
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 in clinical relapses of polymyalgia rheumatica and giant cell arteritis.
Caplanne D; Le Parc JM; Alexandre JA
Ann Rheum Dis; 1996 Jun; 55(6):403-4. PubMed ID: 8694583
[No Abstract] [Full Text] [Related]
9. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch.
Blockmans D; Stroobants S; Maes A; Mortelmans L
Am J Med; 2000 Feb; 108(3):246-9. PubMed ID: 10723979
[No Abstract] [Full Text] [Related]
10. Lymphocyte subpopulations analysis in peripheral blood in polymyalgia rheumatica/giant cell arteritis.
Pountain G; Keogan M; Hazleman B; Brown D
Br J Rheumatol; 1994 Feb; 33(2):194-5. PubMed ID: 8162492
[No Abstract] [Full Text] [Related]
11. Soluble interleukin 2 receptors in polymyalgia rheumatica/giant cell arteritis. Clinical and laboratory correlations.
Salvarani C; Macchioni P; Boiardi L; Rossi F; Casadei Maldini M; Mancini R; Beltrandi E; Spacca C; Lodi L; Portioli I
J Rheumatol; 1992 Jul; 19(7):1100-6. PubMed ID: 1512765
[TBL] [Abstract][Full Text] [Related]
12. Hypothyroidism in polymyalgia rheumatica and giant cell arteritis: lack of any association.
Dasgupta B; Grundy E; Stainer E
BMJ; 1990 Jul; 301(6743):96-7. PubMed ID: 2390592
[No Abstract] [Full Text] [Related]
13. Diagnosing and managing polymyalgia rheumatica and temporal arteritis. Repeated measurements of erythrocyte sedimentation rate are not efficient use of time or resources.
Roome P
BMJ; 1997 Aug; 315(7107):550. PubMed ID: 9329329
[No Abstract] [Full Text] [Related]
14. Frequency of a normal erythrocyte sedimentation rate in patients with active, untreated arteritis temporalis and polymyalgia rheumatica: comment on the article by Helfgott and Kieval.
Olsson AT; Elling H; Elling P
Arthritis Rheum; 1997 Jan; 40(1):191-3. PubMed ID: 9008618
[No Abstract] [Full Text] [Related]
15. [Prevalence of antiphospholipid antibodies in Horton's disease and in polymyalgia rheumatica].
Hulin C; Hachulla E; Michon-Pasturel U; Hatron PY; Masy E; Gillot JM; Caron C; Arvieux J; Flipo RM; Devulder B
Rev Med Interne; 1999 Aug; 20(8):659-63. PubMed ID: 10480168
[TBL] [Abstract][Full Text] [Related]
16. [Comment on rule of thumb 14. Polymyalgia].
Michel BA
Praxis (Bern 1994); 2011 Jun; 100(12):705-6. PubMed ID: 21656497
[No Abstract] [Full Text] [Related]
17. Serum amyloid A concentrations in giant-cell arteritis and polymyalgia rheumatica: a useful test in the management of the disease.
Hachulla E; Saile R; Parra HJ; Hatron PY; Gosset D; Fruchart JC; Devulder B
Clin Exp Rheumatol; 1991; 9(2):157-63. PubMed ID: 1711943
[TBL] [Abstract][Full Text] [Related]
18. Factor VIII-von Willebrand factor in giant cell arteritis and polymyalgia rheumatica.
Persellin ST; Daniels TM; Rings LJ; Kazmier FJ; Bowie EJ; Hunder GG
Mayo Clin Proc; 1985 Jul; 60(7):457-62. PubMed ID: 3925247
[TBL] [Abstract][Full Text] [Related]
19. Temporal arteritis presenting with paresis of the oculomotor nerve, and polymyalgia rheumatica, despite a low erythrocyte sedimentation rate.
Polák P; Pokorný V; Stvrtina S; Tauchmannova H; Malis F; Rovensky J
J Clin Rheumatol; 2005 Aug; 11(4):242-4. PubMed ID: 16357769
[No Abstract] [Full Text] [Related]
20. Selective depletion and activation of CD8+ lymphocytes from peripheral blood of patients with polymyalgia rheumatica and giant cell arteritis.
Dasgupta B; Duke O; Timms AM; Pitzalis C; Panayi GS
Ann Rheum Dis; 1989 Apr; 48(4):307-11. PubMed ID: 2653244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
